株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

薬事業務アウトソーシングの世界市場:市場規模、シェア、動向分析 - サービス(法定代理人、薬事コンサルティング、薬事ライティング・パブリッシング)、地域別 2019年~2026年

Regulatory Affairs Outsourcing Market Size, Share & Trends Analysis Report By Service (Legal Representation, Regulatory Consulting, Regulatory Writing and Publishing), By Region, And Segment Forecasts, 2019 - 2026

発行 Grand View Research, Inc. 商品コード 557185
出版日 ページ情報 英文 92 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=106.08円で換算しております。
Back to Top
薬事業務アウトソーシングの世界市場:市場規模、シェア、動向分析 - サービス(法定代理人、薬事コンサルティング、薬事ライティング・パブリッシング)、地域別 2019年~2026年 Regulatory Affairs Outsourcing Market Size, Share & Trends Analysis Report By Service (Legal Representation, Regulatory Consulting, Regulatory Writing and Publishing), By Region, And Segment Forecasts, 2019 - 2026
出版日: 2019年03月14日 ページ情報: 英文 92 Pages
概要

世界の薬事業務アウトソーシング市場は、2019年から2026年にかけて11.9%のCAGRで推移し139億米ドル規模の市場に成長することが予測されています。医薬品開発業務受託機関(CRO)への薬事業務のアウトソーシングによるコスト効率の向上や、規制機関への申請時間の短縮、品質管理などの利点が、当市場の成長を促進する見通しです。

当レポートでは、薬事業務アウトソーシングの世界市場を調査し、市場の概要、サービス・地域別の市場規模の推移と予測、市場の成長要因および阻害要因の分析、市場機会、競合情勢、主要企業のプロファイルなど、包括的な情報を提供しています。

目次

第1章 調査手法と範囲

  • 市場区分と範囲
  • 情報調達
  • 情報分析
  • 市場形成とデータ可視化
  • データ検証と公開

第2章 エグゼクティブサマリー

第3章 市場変数、市場動向、範囲

  • 市場の見通し
  • 浸透度および成長の見通しのマッピング
  • パイプライン分析:開発段階別
  • 利用者の視点
  • 主要エンドユーザー:製品・地域・国別
  • 規制の枠組み
  • 市場力学
  • 薬事業務アウトソーシング:市場分析ツール

第4章 薬事業務アウトソーシング市場の分析:サービス別

  • 定義と範囲
  • 市場シェア分析:サービス別
  • 市場概要:サービス別
  • 市場分析:サービス別
  • 市場規模の推移と予測:サービス別
    • 薬事コンサルティング
    • 法定代理人
    • 薬事ライティング・パブリッシング
    • 医薬品登録・治験申請
    • その他

第5章 薬事業務アウトソーシング市場の分析:地域別

  • 定義と範囲
  • 市場シェア分析:地域別
  • 市場概要:地域別
  • 市場動向
  • 市場シェア & 主要企業:地域別
  • SWOT分析
  • 市場規模の推移と予測:地域別
    • 北米
    • 欧州
    • アジア太平洋地域
    • 中南米
    • 中東・アフリカ

第6章 競合分析

  • 参入企業、近年の動向、影響分析
  • 企業の分類(イノベーター、マーケットリーダー、新興企業)
  • ベンダー情勢
  • 公営企業
  • 民間企業
  • サプライヤーランキング
  • 主要企業のプロファイル
    • Accell Clinical Research
    • Genpact Ltd
    • Criterium, Inc.
    • PRA Health Sciences, Inc.
    • Promedica International
    • Wuxi AppTec
    • Medpace, Inc.
    • Pharmaceutical Product Development (PPD), LLC
    • PARAXEL International Corporation
    • Charles River Laboratories International, Inc.

第7章 KOLの解説

第8章 提言

図表

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global Regulatory Affairs Outsourcing Market Estimates & Forecasts, by Region, 2015 - 2026 (USD Million)
  • Table 4 Global Regulatory Affairs Outsourcing Market Estimates & Forecasts, by Service, 2015 - 2026 (USD Million)
  • Table 5 North America Regulatory Affairs Outsourcing Market Estimates & Forecasts, by Country, 2015 - 2026 (USD Million)
  • Table 6 North America Regulatory Affairs Outsourcing Market Estimates & Forecasts, by Type, 2015 - 2026 (USD Million)
  • Table 7 U.S. Regulatory Affairs Outsourcing Market Estimates & Forecasts, by Service, 2015 - 2026 (USD Million)
  • Table 8 Canada Regulatory Affairs Outsourcing Market Estimates & Forecasts, by Service, 2015 - 2026 (USD Million)
  • Table 9 Europe Regulatory Affairs Outsourcing Market Estimates & Forecasts, by Country, 2015 - 2026 (USD Million)
  • Table 10 Europe Regulatory Affairs Outsourcing Market Estimates & Forecasts, by Service, 2015 - 2026 (USD Million)
  • Table 11 U.K. Regulatory Affairs Outsourcing Market Estimates & Forecasts, by Service, 2015 - 2026 (USD Million)
  • Table 12 Germany Regulatory Affairs Outsourcing Market Estimates & Forecasts, by Service, 2015 - 2026 (USD Million)
  • Table 13 France Regulatory Affairs Outsourcing Market Estimates & Forecasts, by Service, 2015 - 2026 (USD Million)
  • Table 14 Italy Regulatory Affairs Outsourcing Market Estimates & Forecasts, by Service, 2015 - 2026 (USD Million)
  • Table 15 Spain Regulatory Affairs Outsourcing Market Estimates & Forecasts, by Service, 2015 - 2026 (USD Million)
  • Table 16 Asia Pacific Regulatory Affairs Outsourcing Market Estimates & Forecasts, by Service, 2015 - 2026 (USD Million)
  • Table 17 Japan Regulatory Affairs Outsourcing Market Estimates & Forecasts, by Service, 2015 - 2026 (USD Million)
  • Table 18 China Regulatory Affairs Outsourcing Market Estimates & Forecasts, by Service, 2015 - 2026 (USD Million)
  • Table 19 India Regulatory Affairs Outsourcing Market Estimates & Forecasts, by Service, 2015 - 2026 (USD Million)
  • Table 20 Thailand Regulatory Affairs Outsourcing Market Estimates & Forecasts, by Service, 2015 - 2026 (USD Million)
  • Table 21 South Korea Regulatory Affairs Outsourcing Market Estimates & Forecasts, by Service, 2015 - 2026 (USD Million)
  • Table 22 Latin America Regulatory Affairs Outsourcing Market Estimates & Forecasts, by Service, 2015 - 2026 (USD Million)
  • Table 23 Brazil Regulatory Affairs Outsourcing Market Estimates & Forecasts, by Service, 2015 - 2026 (USD Million)
  • Table 24 Mexico Regulatory Affairs Outsourcing Market Estimates & Forecasts, by Service, 2015 - 2026 (USD Million)
  • Table 25 Argentina Regulatory Affairs Outsourcing Market Estimates & Forecasts, by Service, 2015 - 2026 (USD Million)
  • Table 26 Colombia Regulatory Affairs Outsourcing Market Estimates & Forecasts, by Service, 2015 - 2026 (USD Million)
  • Table 27 Middle East & Africa Regulatory Affairs Outsourcing Market Estimates & Forecasts, by Service, 2015 - 2026 (USD Million)
  • Table 28 Saudi Arabia Regulatory Affairs Outsourcing Market Estimates & Forecasts, by Service, 2015 - 2026 (USD Million)
  • Table 29 South Africa Regulatory Affairs Outsourcing Market Estimates & Forecasts, by Service, 2015 - 2026 (USD Million)
  • Table 30 UAE Regulatory Affairs Outsourcing Market Estimates & Forecasts, by Service, 2015 - 2026 (USD Million)

List of Figures

  • Figure 1 Market research process
  • Figure 2 Information procurement
  • Figure 3 Primary research pattern
  • Figure 4 Market research approaches
  • Figure 5 Value chain based sizing and forecasting
  • Figure 6 QFD modelling for market share assessment
  • Figure 7 Regulatory affairs outsourcing market snapshot
  • Figure 8 Regulatory affairs outsourcing market segmentation
  • Figure 9 Regulatory affairs outsourcing market driver impact
  • Figure 10 Regulatory affairs outsourcing market restraint impact
  • Figure 11 Swot analysis, by Factor (Political & Legal, Economic, and Technological)
  • Figure 12 Porter's five forces analysis
  • Figure 13 Regulatory affairs outsourcing: Service outlook and key takeaways
  • Figure 14 Regulatory affairs outsourcing: Service movement analysis
  • Figure 15 Regulatory affairs consulting market estimates and forecast, 2015 - 2026
  • Figure 16 Regulatory affairs legal representation market estimates and forecast, 2015 - 2026
  • Figure 17 Regulatory writing & publishing market estimates and forecast, 2015 - 2026
  • Figure 18 Product registration & clinical trial application market estimates and forecast, 2015 - 2026
  • Figure 19 Other regulatory services market estimates and forecast, 2015 - 2026
  • Figure 20 Regulatory affairs outsourcing: Regional outlook and key takeaways
  • Figure 21 Regulatory affairs outsourcing: Regional movement analysis
  • Figure 22 North America market estimates and forecast, 2015 - 2026
  • Figure 23 U.S. market estimates and forecast, 2015 - 2026
  • Figure 24 Canada market estimates and forecast, 2015 - 2026
  • Figure 25 Europe market estimates and forecast, 2015 - 2026
  • Figure 26 U.K. market estimates and forecast, 2015 - 2026
  • Figure 27 Germany market estimates and forecast, 2015 - 2026
  • Figure 28 France market estimates and forecast, 2015 - 2026
  • Figure 29 Italy market estimates and forecast, 2015 - 2026
  • Figure 30 Spain market estimates and forecast, 2015 - 2026
  • Figure 31 Asia Pacific market estimates and forecast, 2015 - 2026
  • Figure 32 Japan market estimates and forecast, 2015 - 2026
  • Figure 33 China market estimates and forecast, 2015 - 2026
  • Figure 34 India market estimates and forecast, 2015 - 2026
  • Figure 35 Australia market estimates and forecast, 2015 - 2026
  • Figure 36 South Korea market estimates and forecast, 2015 - 2026
  • Figure 37 Latin America market estimates and forecast, 2015 - 2026
  • Figure 38 Brazil market estimates and forecast, 2015 - 2026
  • Figure 39 Mexico market estimates and forecast, 2015 - 2026
  • Figure 40 Argentina market estimates and forecast, 2015 - 2026
  • Figure 41 Colombia market estimates and forecast, 2015 - 2026
  • Figure 42 Middle East & Africa market estimates and forecast, 2015 - 2026
  • Figure 43 Saudi Arabia market estimates and forecast, 2015 - 2026
  • Figure 44 South Africa market estimates and forecast, 2015 - 2026
  • Figure 45 UAE market estimates and forecast, 2015 - 2026
目次
Product Code: GVR-1-68038-556-4

The global regulatory affairs outsourcing market size is expected to reach USD 13.9 billion by 2026, according to a new report by Grand View Research, Inc. it is projected to register a CAGR of 11.9% during the forecast period. Outsourcing regulatory affairs activities to the Contract Research Organizations (CROs) offers cost efficiency, reduced regulatory submission time, and quality control in the overall manufacturing process. These factors are anticipated to propel the growth over the forecast period.

Large companies address capacity problems and lack of expertise in their internal departments through outsourcing to smaller mid-size companies. It also eliminates additional work load and consolidates regulatory departments to avoid duplication of work. Regulatory affairs include activities such as drug master files, technical writing, and review of Chemistry, Manufacturing, and Controls (CMC), eCTD conversion, query management, Investigational New Drug (IND) maintenance, serious adverse events reporting, labeling, and drug shipment approvals for clinical trials.

Regulatory affairs outsourcing witnessed few important industry events. For instance, in August 2018, U.K. based Syneos Health acquired Kinapse, a provider of pharmaco-vigilance consulting and post market regulatory services. With this acquisition, the company aims to double its consulting footprint in Europe and associated commercial services. Moreover, in October 2018, PAREXEL International Corporation introduced the new China Advisory Services to help pharmaceutical companies in seeking market opportunities within China, to have an early mover advantage. The services include agency engagements, market access, and commercial strategies. This happened on the backdrop of recent reforms implemented by the National Medicinal Products Administration (NMPA), such as expedited approvals, faster Multi-regional Clinical Trials (MCT) applications, and clinical trial approvals in two months.

Further key findings from the report suggest:

  • The regulatory writing and publishing emerged as the largest segment with a market share of over 35.0% in 2018. Legal representation segment is expected to register the highest CAGR of 12.8%, over the forecast period, owing to regulatory reforms in the emerging nations
  • North America regulatory affairs outsourcing market held the market share of over 20.0%, in 2018 owing to rising requirements in the region. Moreover, presence of big pharmaceutical and biotech companies seeking workload management is also favoring regional growth
  • Asia Pacific is expected to witness substantial growth in near future, owing to unmet needs of the huge population base, low labor cost, and improving healthcare infrastructure

Some of the companies operating in the market include: Accell Clinical Research; PRA International; PAREXEL International Corporation; Quintiles Transnational Holdings; Charles River Laboratories International Inc.; Clinilabs Inc.; Criterium Inc.; Wuxi AppTec; and Medpace Inc.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market segmentation & scope
  • 1.2 Information procurement
    • 1.2.1 Purchased database
    • 1.2.2 GVR's internal database
    • 1.2.3 Secondary sources & third party perspectives
    • 1.2.4 Primary research
  • 1.3 Information analysis
    • 1.3.1 Data analysis models
  • 1.4 Market formulation & data visualization
  • 1.5 Data validation & publishing

Chapter 2 Executive Summary

  • 2.1 Market Outlook
  • 2.2 Segment Outlook
  • 2.3 Competitive Insights

Chapter 3 Regulatory Affairs Outsourcing Market Variables, Trends & Scope

  • 3.1 Market Lineage outlook
    • 3.1.1 Parent market outlook
    • 3.1.2 Related/ancillary market outlook
  • 3.2 Penetration & Growth Prospect Mapping
  • 3.3 Product Pipeline Analysis, by Stage
  • 3.4 User perspective analysis
    • 3.4.1 Consumer Behavior Analysis
    • 3.4.2 Market Influencer Analysis
  • 3.5 List of Key End-users, by region / by product / by country
  • 3.6 Regulatory Framework
    • 3.6.1 Reimbursement framework
    • 3.6.2 Standards & Compliances
  • 3.7 Market Dynamics
    • 3.7.1 Market Driver Analysis
      • 3.7.1.1 Changing regulatory landscape
      • 3.7.1.2 Economic and competitive pressures
      • 3.7.1.3 Growth in emerging areas such as personalized medicine, biosimilars, and orphan drugs
    • 3.7.2 Market Restraint Analysis
      • 3.7.2.1 Monitoring issues and lack of standardization
      • 3.7.2.2 Risk associated with data security
    • 3.7.3 Industry Challenges
      • 3.7.3.1 Implementation of changing rules
  • 3.8 Regulatory Affairs Outsourcing: Market Analysis Tools
    • 3.8.1 Industry Analysis - Porter's
      • 3.8.1.1 Supplier Power: (Low)
      • 3.8.1.2 Buyer Power: (Low)
      • 3.8.1.3 Substitution Threat: (Low)
      • 3.8.1.4 Threat from new entrant: (Moderate)
      • 3.8.1.5 Competitive rivalry: (High)
    • 3.8.2 PESTEL Analysis
      • 3.8.2.1 Political Landscape
      • 3.8.2.2 Environmental Landscape
      • 3.8.2.3 Social Landscape
      • 3.8.2.4 Technology Landscape
      • 3.8.2.5 Legal Landscape
    • 3.8.3 Major Deals & Strategic Alliances Analysis
      • 3.8.3.1 Joint Ventures
      • 3.8.3.2 Mergers & Acquisitions
      • 3.8.3.3 Licensing & Partnership
      • 3.8.3.4 Technology Collaborations
      • 3.8.3.5 Strategic Divestments
    • 3.8.4 Market Entry Strategies

Chapter 4 Regulatory Affairs Outsourcing Market: Segment Analysis, By Service, 2015 - 2026 (USD Million)

  • 4.1 Definitions & Scope
  • 4.2 Services market share analysis, 2018 & 2026
  • 4.3 Segment Dashboard
  • 4.4 Global Regulatory Affairs Outsourcing Market, by Service, 2015 to 2026
  • 4.5 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the following
    • 4.5.1 Regulatory consulting
    • 4.5.2 Legal representation
    • 4.5.3 Regulatory writing and publishing
    • 4.5.4 Product registration and clinical trial application
    • 4.5.5 Other regulatory services

Chapter 5 Regulatory Affairs Outsourcing Market: Regional Market Analysis, 2015 - 2026 (USD Million)

  • 5.1 Definitions & Scope
  • 5.2 Regional market share analysis, 2018 & 2026
  • 5.3 Regional Market Dashboard
  • 5.4 Regional Market Snapshot (Market Size, CAGR, Top Verticals, Key Players, Top Trends)
  • 5.5 Regional Market Share and Leading Players, 2018
    • 5.5.1 North America
    • 5.5.2 Europe
    • 5.5.3 Asia Pacific
    • 5.5.4 Latin America
    • 5.5.5 Middle East & Africa
  • 5.6 SWOT Analysis, by Factor (Political & Legal, Economic And Technological)
    • 5.6.1 North America
    • 5.6.2 Europe
    • 5.6.3 Asia Pacific
    • 5.6.4 Latin America
    • 5.6.5 Middle East & Africa
  • 5.7 Market Size, & Forecasts, Value and Trend Analysis, 2018 to 2025:
  • 5.8 North America
    • 5.8.1 Market estimates and forecast, by country, 2015 - 2026 (USD Million)
    • 5.8.2 Market estimates and forecast, by product, 2015 - 2026 (USD Million)
    • 5.8.3 U.S.
      • 5.8.4.1 Market estimates and forecast, by product, 2015 - 2026 (USD Million)
    • 5.8.5 Canada
      • 5.8.5.1 Market estimates and forecast, by product, 2015 - 2026 (USD Million)
  • 5.9 Europe
    • 5.9.1 Market estimates and forecast, by country, 2015 - 2026 (USD Million)
    • 5.9.2 Market estimates and forecast, by product, 2015 - 2026 (USD Million)
    • 5.9.3 Germany
      • 5.9.4.1 Market estimates and forecast, by product, 2015 - 2026 (USD Million)
    • 5.9.5 U.K.
      • 5.9.5.1 Market estimates and forecast, by product, 2015 - 2026 (USD Million)
    • 5.9.6 France
      • 5.9.6.1 Market estimates and forecast, by product, 2015 - 2026 (USD Million)
    • 5.9.7 Italy
      • 5.9.7.1 Market estimates and forecast, by product, 2015 - 2026 (USD Million)
    • 5.9.8 Spain
      • 5.9.8.1 Market estimates and forecast, by product, 2015 - 2026 (USD Million)
  • 5.10 Asia Pacific
    • 5.10.1 Market estimates and forecast, by country, 2015 - 2026 (USD Million)
    • 5.10.2 Market estimates and forecast, by product, 2015 - 2026 (USD Million)
    • 5.10.4 China
      • 5.10.4.1 Market estimates and forecast, by product, 2015 - 2026 (USD Million)
    • 5.10.5 Japan
      • 5.10.5.1 Market estimates and forecast, by product, 2015 - 2026 (USD Million)
    • 5.10.6 India
      • 5.10.6.1 Market estimates and forecast, by product, 2015 - 2026 (USD Million)
    • 5.10.7 Australia
      • 5.10.7.1 Market estimates and forecast, by product, 2015 - 2026 (USD Million)
    • 5.10.8 South Korea
      • 5.10.8.1 Market estimates and forecast, by product, 2015 - 2026 (USD Million)
  • 5.11 Latin America
    • 5.11.1 Market estimates and forecast, by country, 2015 - 2026 (USD Million)
    • 5.11.2 Market estimates and forecast, by product, 2015 - 2026 (USD Million)
    • 5.11.3 Brazil
      • 5.11.3.1 Market estimates and forecast, by product, 2015 - 2026 (USD Million)
    • 5.11.4 Mexico
      • 5.11.5.1 Market estimates and forecast, by product, 2015 - 2026 (USD Million)
    • 5.11.5 Argentina
      • 5.11.6.1 Market estimates and forecast, by product, 2015 - 2026 (USD Million)
    • 5.11.6 Colombia
      • 5.11.7.1 Market estimates and forecast, by product, 2015 - 2026 (USD Million)
  • 5.12 Middle East & Africa
    • 5.12.1 Market estimates and forecast, by country, 2015 - 2026 (USD Million)
    • 5.12.2 Market estimates and forecast, by product, 2015 - 2026 (USD Million)
    • 5.12.3 South Africa
      • 5.12.3.1 Market estimates and forecast, by product, 2015 - 2026 (USD Million)
    • 5.12.5 Saudi Arabia
      • 5.12.5.1 Market estimates and forecast, by product, 2015 - 2026 (USD Million)
    • 5.12.6 UAE
      • 5.12.6.1 Market estimates and forecast, by product, 2015 - 2026 (USD Million)

Chapter 6 Regulatory Affairs Outsourcing Market - Competitive Analysis

  • 6.1 Recent developments & impact analysis, by key market participants
  • 6.2 Company/Competition Categorization (Key innovators, Market leaders, Emerging players)
  • 6.3 Vendor Landscape
    • 6.3.1 List of key distributors and channel partners
    • 6.3.2 Key customers
    • 6.3.3 Key company market share analysis, 2018
  • 6.4 Public Companies
    • 6.4.1 Company market position analysis (Revenue, geographic presence, product portfolio, key serviceable industries, key alliances)
    • 6.4.2 Company Market Share/Ranking, by region
    • 6.4.3 Competitive Dashboard Analysis
      • 6.4.3.1 Market Differentiators
      • 6.4.3.2 Synergy Analysis: Major Deals & Strategic Alliances
  • 6.5 Private Companies
    • 6.5.1 List of key emerging companies' /technology disruptors/innovators
    • 6.5.2 Funding Outlook (Optional)
    • 6.5.3 Regional network map
    • 6.5.4 Company market position analysis (geographic presence, product portfolio, key alliance, industry experience)
  • 6.6 Supplier Ranking
  • 6.7 Key companies profiled
    • 6.7.1 Accell Clinical Research
      • 6.7.1.1 Company Overview
      • 6.7.1.2 Financial Performance
      • 6.7.1.3 Product Benchmarking
      • 6.7.1.4 Strategic Initiatives
    • 6.7.2 Genpact Ltd
      • 6.7.2.1 Company Overview
      • 6.7.2.2 Financial Performance
      • 6.7.2.3 Product Benchmarking
      • 6.7.2.4 Strategic Initiatives
    • 6.7.3 Criterium, Inc.
      • 6.7.3.1 Company Overview
      • 6.7.3.2 Financial Performance
      • 6.7.3.3 Product Benchmarking
      • 6.7.3.4 Strategic Initiatives
    • 6.7.4 PRA Health Sciences, Inc.
      • 6.7.4.1 Company Overview
      • 6.7.4.2 Financial Performance
      • 6.7.4.3 Product Benchmarking
      • 6.7.4.4 Strategic Initiatives
    • 6.7.5 Promedica International
      • 6.7.5.1 Company Overview
      • 6.7.5.2 Financial Performance
      • 6.7.5.3 Product Benchmarking
      • 6.7.5.4 Strategic Initiatives
    • 6.7.6 Wuxi AppTec
      • 6.7.6.1 Company Overview
      • 6.7.6.2 Financial Performance
      • 6.7.6.3 Product Benchmarking
      • 6.7.6.4 Strategic Initiatives
    • 6.7.7 Medpace, Inc.
      • 6.7.7.1 Company Overview
      • 6.7.7.2 Financial Performance
      • 6.7.7.3 Product Benchmarking
      • 6.7.7.4 Strategic Initiatives
    • 6.7.8 Pharmaceutical Product Development (PPD), LLC
      • 6.7.8.1 Company Overview
      • 6.7.8.2 Financial Performance
      • 6.7.8.3 Product Benchmarking
      • 6.7.8.4 Strategic Initiatives
    • 6.7.9 PARAXEL International Corporation
      • 6.7.9.1 Company Overview
      • 6.7.9.2 Financial Performance
      • 6.7.9.3 Product Benchmarking
      • 6.7.9.4 Strategic Initiatives
    • 6.7.10 Charles River Laboratories International, Inc.
      • 6.7.10.1 Company Overview
      • 6.7.10.2 Financial Performance
      • 6.7.10.3 Product Benchmarking
      • 6.7.10.4 Strategic Initiatives

Chapter 7 KOL Commentary

Chapter 8 Recommendations

Back to Top